HA Plus 100DT Cream Toning Light

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: HA Plus 100DT Cream Toning Light
Generic name: NIACINAMIDE, ADENOSINE
Manufacturer: LAON COMMERCE co ltd
Product type: HUMAN OTC DRUG
SPL set ID: fdab530e-bd72-1f12-e053-6394a90a971d
SPL ID: fdab3553-fb9b-47ec-e053-6394a90aacf8
Version: 1
Effective date: 2023-06-08
Source export date: 2026-09-28
Source partition: 10
Source file: https://download.open.fda.gov/drug/label/drug-label-0010-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/4bbc9760f647649b787710953d978bd6419e899ba8b90f32c3d972aae43947f8/drug-label-0010-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:14:09

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 10 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		HA Plus 100DT Cream Toning Light	openfda.brand_name
generic name		NIACINAMIDE, ADENOSINE	openfda.generic_name
manufacturer name		LAON COMMERCE co ltd	openfda.manufacturer_name
ndc	package	82083-0019-1	openfda.package_ndc
ndc	product	82083-0019	openfda.product_ndc
ndc11	package	82083001901	derived:openfda.package_ndc
spl id		fdab3553-fb9b-47ec-e053-6394a90aacf8	id
spl set id		fdab530e-bd72-1f12-e053-6394a90a971d	set_id
unii		25X51I8RD4	openfda.unii
unii		K72T3FS567	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

1. During using product or after use, if there are any abnormal symptoms or side effects such as red spots, swelling or itching in the area of use due to direct sunlight, consult with a specialist. 2. Refrain from using on areas with scars, etc. 3. Precautions for storage and handling A) Keep out of reach of children B) Store away from direct sunlight

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.